BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 21, 2014
View Archived Issues
Tumor profiling service could help determine optimal therapy for urothelial carcinoma
Read More
Scientists develop plant-derived immunogenic vaccine for atherosclerosis
Read More
Nuvo Research sells Pennsaid 2% U.S. rights to Horizon Pharma
Read More
Batu Biologics signs license agreement with UC San Diego
Read More
Results from the first study of fidaxomicin in pediatric patients with CDAD
Read More
Fispemifene licensed to Apricus Biosciences
Read More
HMB-45 staining increases after UVB treatment for vitiligo
Read More
Cystic fibrosis candidate N-6022 well tolerated in phase I study
Read More
First-in-human results on Novartis new antimalarial drug candidate
Read More
Takeda Pharmaceutical confirms U.S. launch of Contrave
Read More
Baxter launches Hyqvia in the U.S. for adults with primary immunodeficiency
Read More
NewLink Genetics enters into exclusive worldwide licensing agreement for NLG-919
Read More
FDA grants fast track designation to TAS-102 for refractory metastatic colorectal cancer
Read More
Matinas BioPharma submits IND for MAT-9001 for severe hypertriglyceridemia
Read More
Pharmacyclics files sNDA for Imbruvica for Waldenstrom's macroglobulinemia
Read More
FDA accepts for review a BLA for pediatric hexavalent vaccine
Read More
EMA grants orphan drug designation to isactuzumab govitecan
Read More
CK18 as a potential predictor of type 2 diabetes in patients with NAFLD
Read More
Taisho submits Japanese filing for esflurbiprofen patch for osteoarthritis
Read More
GLPG-1205 demonstrates good safety in a phase I study
Read More
TesoRx and Aspen sign license agreement for bio-identical oral testosterone replacement therapy
Read More
FDA advisory committee recommends approval of secukinumab for plaque psoriasis
Read More
FDA approves Xiaflex to treat up to two joints in Dupuytren's contracture
Read More
Ofev launched in U.S.
Read More
RegeneRx allowed to advance RGN-259 into phase III for neurotrophic keratopathy
Read More